Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17,417,453
-
Total 13F shares
-
7,107,091
-
Share change
-
+1,109,805
-
Total reported value
-
$20,255,014
-
Price per share
-
$2.85
-
Number of holders
-
19
-
Value change
-
+$3,161,740
-
Number of buys
-
5
-
Number of sells
-
8
Institutional Holders of Insight Molecular Diagnostics Inc. - Common Stock (IMDX) as of Q3 2024
As of 30 Sep 2024,
Insight Molecular Diagnostics Inc. - Common Stock (IMDX) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,107,091 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, AWM Investment Company, Inc., PURA VIDA INVESTMENTS, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., MORGAN STANLEY, FNY Investment Advisers, LLC, STATE STREET CORP, and NORTHERN TRUST CORP.
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.